Men in Britain are choosing not to have aggressive cancer treatments at initial diagnosis.
This is according to a recent study conducted by Dr Chris Parker from the Institute of Cancer Research.
According to Dr Parker, men in the UK with prostate cancer are showing an increasing preference for Active Surveillance.
The Active Surveillance technique, which has been recommended by the National Institute for Health and Clinical Excellence (NICE) since 2008, involves closely monitoring a person's condition.
It is recommended for patients with low-risk, localised prostate cancer.
Almost four in ten men in the UK chose this method of treatment in 2006, Dr Parker discovered.
He commented: "This is the first study to examine the treatment choices of men diagnosed with low-risk prostate cancer in the UK and it demonstrates a major increase over time in the use of Active Surveillance."
"This growth … represents a significant shift of clinical practice in Britain and contrasts sharply with the US where about 95 per cent of low-risk patients have radical treatment."